All In MedTech

Device Trial Radar · NCT05120193

Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System

Treatment of Persistent Atrial Fibrillation With the Sphere-9 Mapping and Ablation Catheter and the Affera Mapping and Ablation System

Last checked: Nov 20, 2026Latest source record: Apr 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 477 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

477

Actual

Start

Dec 14, 2021

Primary completion

Jan 10, 2024

Study completion Jan 10, 2024

Sponsor

Lead sponsor
Medtronic Cardiac Ablation SolutionsPublic (MDT)
Sponsor type
Industry
First posted
Nov 15, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, multicenter, randomized clinical evaluation of the Sphere-9 Mapping and Ablation Catheter with the Affera Mapping and Ablation System. Subjects will be randomly assigned 1:1 to receive treatment with either the Sphere-9 Mapping and Ablation Catheter and the Affera Mapping and Ablation System (investigational device) or the THERMOCOOL SMARTTOUCH® SF radiofrequency ablation catheter (control device).

Conditions

  • Atrial Fibrillation

Interventions

  • Mapping and AblationDevice

    Minimally invasive catheter mapping and ablation procedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of Subjects With a Primary Adverse EventTime frame: 180 Days
  2. Percent of Subjects Free From Primary Effectiveness FailureTime frame: 12 months

Locations

23 sites in 3 countries. Site status is shown where the registry gives one.

  • Arrhythmia Institute at Grandview

    Birmingham, Alabama

  • Banner University Medical Center Phoenix

    Phoenix, Arizona

  • Arrhythmia Research Group

    Jonesboro, Arkansas

20 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.